Beacon Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Beacon Financial Group's NVO Position: Q1 2026 in Review
Beacon Financial Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,248 shares — an estimated $216K sold.
Beacon Financial Group first reported a position in NVO in Q3 2013 and held it in 15 quarters. The position peaked at $798K in Q1 2015. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Beacon Financial Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Beacon Financial Group sold 4,248 Novo Nordisk shares in Q1 2026, an estimated $216K.
- Beacon Financial Group first reported a position in Novo Nordisk in Q3 2013 and held it in 15 quarters.
- Beacon Financial Group's Novo Nordisk position peaked at $798K in Q1 2015.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Beacon Financial Group's 13F filing for Q1 2026, filed 30 Apr 2026.